Hirth Peter — SEC insider filings
SEC reporting owner CIK 1813780. 18 insider filings on record with FilingPulse; latest filed 2026-10-08.
Transaction summary — filings shown
Covers all 18 filings on record, filed 2021-06-03 to 2026-10-08. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 21.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Aligos Therapeutics, Inc. (ALGS) | Director | 7 | — | — | 8 |
| Vaxcyte, Inc. (PCVX) | Director | 4 | — | — | 7 |
| IO Biotech, Inc. (IOBT) | Director | 5 | — | — | 5 |
| TRex Bio, Inc. (TRXB) | Director | 2 | — | — | 1 |
Insider filings — Hirth Peter
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-10-08 | 3 | TRex Bio, Inc. (TRXB) | Holdings only — no transactions reported | EDGAR |
| 2026-10-08 | 4 | TRex Bio, Inc. (TRXB) | Grant/award (A): 17,500 (derivative) @ $0 | EDGAR |
| 2026-06-29 | 4 | Aligos Therapeutics, Inc. (ALGS) | Grant/award (A): 5,860 (derivative) @ $0 | EDGAR |
| 2025-06-26 | 4 | Aligos Therapeutics, Inc. (ALGS) | Grant/award (A): 5,860 (derivative) @ $0 | EDGAR |
| 2025-06-06 | 4 | IO Biotech, Inc. (IOBT) | Grant/award (A): 35,144 (derivative) @ $0 | EDGAR |
| 2024-06-28 | 4 | Aligos Therapeutics, Inc. (ALGS) | Grant/award (A): 60,000 (derivative) @ $0 | EDGAR |
| 2024-06-10 | 4 | Vaxcyte, Inc. (PCVX) | Grant/award (A): 1,550 @ $0 · Grant/award (A): 7,250 (derivative) @ $0 | EDGAR |
| 2024-06-07 | 4 | IO Biotech, Inc. (IOBT) | Grant/award (A): 45,642 (derivative) @ $0 | EDGAR |
| 2024-02-28 | 4 | Aligos Therapeutics, Inc. (ALGS) | Disposition to issuer (D): 15,000 (derivative) @ $0 · Grant/award (A): 4,411 (derivative) @ $0 | EDGAR |
| 2023-07-21 | 4 | Aligos Therapeutics, Inc. (ALGS) | Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
| 2023-06-15 | 4 | Vaxcyte, Inc. (PCVX) | Grant/award (A): 2,500 @ $0 · Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2023-06-13 | 4 | IO Biotech, Inc. (IOBT) | Grant/award (A): 41,533 (derivative) @ $0 | EDGAR |
| 2022-06-27 | 4 | Aligos Therapeutics, Inc. (ALGS) | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2022-06-03 | 4 | Vaxcyte, Inc. (PCVX) | Grant/award (A): 3,125 @ $0 · Grant/award (A): 18,750 (derivative) @ $0 | EDGAR |
| 2022-05-31 | 4 | IO Biotech, Inc. (IOBT) | Grant/award (A): 23,885 (derivative) @ $0 | EDGAR |
| 2021-11-08 | 4 | IO Biotech, Inc. (IOBT) | Grant/award (A): 34,731 (derivative) @ $0 | EDGAR |
| 2021-06-17 | 4 | Aligos Therapeutics, Inc. (ALGS) | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2021-06-03 | 4 | Vaxcyte, Inc. (PCVX) | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2021-06-02 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1813780 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs